T1	Participants 76 97	posterior blepharitis
T2	Participants 12 55	topical azithromycin ophthalmic solution 1%
T3	Participants 113 125	Azithromycin
T4	Participants 387 610	opical azithromycin ophthalmic solution 1% (AzaSite; Inspire Pharmaceuticals, Inc, NC, USA) combined with warm compresses (azithromycin group) to warm compresses alone (compress group) in patients with posterior blepharitis
T5	Participants 620 676	Twenty-one patients diagnosed with posterior blepharitis
T6	Participants 734 781	azithromycin plus warm compresses (10 patients)
T7	Participants 786 816	compresses alone (11 patients)
T8	Participants 818 830	All patients
T9	Participants 921 955	Each eye in the azithromycin group
T10	Participants 856 878	compresses to each eye
T11	Participants 1079 1087	Patients
T12	Participants 1187 1318	five clinical signs: eyelid debris, eyelid redness, eyelid swelling, meibomian gland (MG) plugging, and the quality of MG secretion
T13	Participants 1332 1340	patients
T14	Participants 1404 1419	Twenty patients
T15	Participants 1453 1487	patients in the azithromycin group
T16	Participants 1640 1741	MG plugging resolved completely in three patients and MG secretion returned to normal in two patients
